Retina/Vitreous

Top Story

Artificial intelligence-based algorithm screens for diabetic retinopathy

March 29, 2017

A novel artificial intelligence-based algorithm proved effective as a tool to automate screening for diabetic retinopathy, according to a study.

Deep learning methods were used to process 75,137 color fundus images of patients with diabetes obtained from the EyePACS public data set. The artificial intelligence model was trained and tested to detect and differentiate the features of healthy eye fundi from eye fundi with DR.

In the Journals

Aflibercept for AMD largely maintains visual gains through 212 weeks

March 28, 2017
Vision gains achieved in the VIEW 1 trial were “largely maintained” at the conclusion of the VIEW 1 Extension Study, according to the study results. In the…
Perspectives on Glaucoma

Central vision loss affects daily tasks more than peripheral

March 28, 2017
Patients with central vision loss due to age-related macular degeneration have greater difficulty in visually guided manual prehension and object placement as compared…

IBM Watson, IDx collaborate on imaging applications

March 28, 2017
IBM Watson Health and IDx LLC announced a 5-year strategic alliance to advance eye health through cognitive computing applications to aid primary care providers…
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
Video
Meeting News

VIDEO: Genetic therapies are the future in AMD treatment

March 3, 2017
More »
Featured
SECO

SECO

Video
Meeting News

VIDEO: Now is time to 'test drive' intraoperative 3D digital viewing systems

January 19, 2017
More »
In the Journals

Artificial intelligence-based algorithm screens for diabetic retinopathy

March 29, 2017
A novel artificial intelligence-based algorithm proved effective as a tool to automate screening for diabetic retinopathy, according to a study. …

In the Journals

Aflibercept for AMD largely maintains visual gains through 212 weeks

March 28, 2017
Vision gains achieved in the VIEW 1 trial were “largely maintained” at the conclusion of the VIEW 1 Extension Study, according to the…

Perspectives on Glaucoma

Central vision loss affects daily tasks more than peripheral

March 28, 2017
Patients with central vision loss due to age-related macular degeneration have greater difficulty in visually guided manual prehension and object…

IBM Watson, IDx collaborate on imaging applications

March 28, 2017
IBM Watson Health and IDx LLC announced a 5-year strategic alliance to advance eye health through cognitive computing applications to aid primary…

In the Journals

Teleretinal diabetic retinopathy screening program decreases need for referrals

March 27, 2017
Screening rates were increased and both the need for referral and wait time for screening were reduced for patients who participated in a large-scale…

PUBLICATION EXCLUSIVE: Which DRCR.net protocol has had the biggest impact on your practice?

March 25, 2017
Click here to view the Cover Story for this Point/Counter.

ONL Therapeutics receives approximately $1 million grant from NEI

March 23, 2017
The National Eye Institute has awarded ONL Therapeutics a grant worth almost $1 million to continue developing its lead therapeutic candidate…

PUBLICATION EXCLUSIVE: ASCRS Research Council aims to mirror success of DRCR.net

March 22, 2017
The Diabetic Retinopathy Clinical Research Network is a collaboration among the National Eye Institute, the National Institute of Diabetes and…

Phase 1/2 trial of gene therapy treatment for X-linked retinitis pigmentosa begins

March 22, 2017
A phase 1/2 clinical trial of a gene therapy treatment for X-linked retinitis pigmentosa has begun enrolling and dosing subjects, NightstaRx…

Publication Exclusive

PUBLICATION EXCLUSIVE: Woman presents with cloudy declining vision and flashes

March 20, 2017
A 56-year-old Caucasian woman presented with painless, slowly decreasing “murky” vision in the left eye over a period of 3 weeks, along…

More Headlines »
Advertisement
Advertisement